Zacks Investment Research upgraded
Fujifilm Holdings Corporation
) to a Zacks Rank #1 (Strong Buy) on Jul 9, based on its efforts to
Why the Upgrade?
Fujifilm has been successfully launching new products and
technologies to gain a wider market share in the digital world.
Recently, the company launched a technology that can change the
impression of an image by controlling its texture, i.e. colors and
shapes, based on human visual perception. This technology is useful
in enhancing the visibility and shape of an image. Moreover, the
company launched new firmware for three X-series cameras last
In addition, Fujifilm expects its pharmaceuticals business to
gain traction in the coming quarters and be a source of high
revenue. The Medical Systems business is expected to witness double
digit year over year growth in fiscal 2015. Also, sales in the
Toyama Chemical and Fujifilm Pharma are anticipated to rise in the
Fujifilm expects revenues for fiscal 2015 to come at ¥2,460
billion, reflecting a year-over-year hike of 0.8%. Operating income
is projected at ¥160.0 billion, with an increase of 13.6% from
fiscal 2014. Further, Fujifilm estimates the net income for fiscal
2015 at ¥85.0 billion, rising 4.9% year over year. This will lead
to earnings of ¥176.36 per American Depositary Receipt (ADR).
Over the past seven days, the Zacks Consensus Estimate for
fiscal 2015 has climbed 2.3% to $1.79 per ADR. The company is
expected to report fiscal first-quarter 2015 results (ended Jun 30,
2014) on Jul 30.
Other Stocks to Consider
Other stocks in the industry with a favorable Zacks Rank include
Brooks Automation, Inc.
). All these stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
CIENA CORP (CIEN): Free Stock Analysis Report
FUJIFILM HLDGS (FUJIY): Free Stock Analysis
BROOKS AUTOMATN (BRKS): Free Stock Analysis
ENTEGRIS INC (ENTG): Free Stock Analysis Report
To read this article on Zacks.com click here.